A detailed history of Sutton Wealth Advisors Inc. transactions in Incyte Corp stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 110 shares of INCY stock, worth $7,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 41 168.29%
Holding current value
$7,422
Previous $2.55 Million 149.02%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$57.77 - $65.93 $3,986 - $4,549
69 Added 168.29%
110 $6.36 Million
Q2 2023

Nov 08, 2023

SELL
$60.95 - $75.51 $1,950 - $2,416
-32 Reduced 43.84%
41 $2.55 Million
Q1 2023

Nov 07, 2023

SELL
$70.23 - $86.01 $1,053 - $1,290
-15 Reduced 17.05%
73 $5.28 Million
Q3 2022

Nov 07, 2023

SELL
$66.18 - $82.86 $198 - $248
-3 Reduced 3.3%
88 $5.86 Million
Q1 2022

Nov 07, 2023

BUY
$66.02 - $79.71 $1,254 - $1,514
19 Added 26.39%
91 $7.23 Million
Q4 2021

Nov 07, 2023

BUY
$63.34 - $74.11 $2,976 - $3,483
47 Added 188.0%
72 $5.29 Million
Q3 2021

Nov 07, 2023

SELL
$68.67 - $84.02 $1,373 - $1,680
-20 Reduced 44.44%
25 $1.72 Million
Q1 2021

Nov 07, 2023

SELL
$76.02 - $100.5 $76 - $100
-1 Reduced 2.17%
45 $3.66 Million
Q4 2020

Nov 07, 2023

BUY
$80.74 - $97.7 $645 - $781
8 Added 21.05%
46 $4 Million
Q3 2020

Nov 07, 2023

SELL
$85.07 - $109.69 $935 - $1,206
-11 Reduced 22.45%
38 $3.41 Million
Q2 2020

Nov 07, 2023

BUY
$74.18 - $108.93 $370 - $544
5 Added 11.36%
49 $5.1 Million
Q1 2020

Nov 07, 2023

BUY
$63.18 - $85.97 $1,263 - $1,719
20 Added 83.33%
44 $3.22 Million
Q2 2019

Nov 06, 2023

BUY
$73.52 - $88.7 $588 - $709
8 Added 50.0%
24 $2.04 Million
Q1 2019

Nov 06, 2023

BUY
$63.56 - $88.17 $317 - $440
5 Added 45.45%
16 $1.38 Million
Q4 2018

Nov 06, 2023

BUY
$58.5 - $69.94 $234 - $279
4 Added 57.14%
11 $699,000
Q3 2018

Nov 06, 2023

SELL
$61.75 - $74.23 $9,015 - $10,837
-146 Reduced 95.42%
7 $484,000
Q1 2018

Nov 06, 2023

SELL
$83.06 - $100.98 $996 - $1,211
-12 Reduced 7.27%
153 $12.7 Million
Q4 2017

Nov 06, 2023

SELL
$93.56 - $116.6 $6,549 - $8,162
-70 Reduced 29.79%
165 $15.6 Million
Q3 2017

Nov 06, 2023

BUY
$109.15 - $138.27 $1,309 - $1,659
12 Added 5.38%
235 $27.4 Million
Q2 2017

Nov 06, 2023

BUY
N/A
70 Added 45.75%
223 $28.1 Million
Q1 2016

Nov 06, 2023

BUY
N/A
153
153 $11.1 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.